Director Srinivas Akkaraju sold $2.1M of Syros Pharmaceuticals, Inc.

Sold$2,086,396

$13.10Price

159,327Shares

−11%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Mon, Aug 17. Filed Wed, Aug 19, 12:03 PM ET, during the session. Not investment advice.